Vakaramoko Diaby to Adult
This is a "connection" page, showing publications Vakaramoko Diaby has written about Adult.
Connection Strength
0.594
-
Nkemdirim Okere A, Moussa RK, Ali A, Diaby VK. Development and validation of a tool to predict high-need, high-cost patients hospitalised with ischaemic heart disease. BMJ Open. 2023 09 26; 13(9):e073485.
Score: 0.077
-
Sanogo V, Chen Z, Almutairi RD, Hong X, Diaby V. Predictors of 30-day readmission, mortality, and length of stay for hospitalized U.S. patients with Alzheimer's and related dementias from 2010 to 2015. Expert Rev Pharmacoecon Outcomes Res. 2023 Jun; 23(5):555-559.
Score: 0.074
-
Babcock A, Moussa RK, Diaby V. Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar; 22(2):247-258.
Score: 0.065
-
Okere AN, Sanogo V, Alqhtani H, Diaby V. Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct; 21(5):1043-1048.
Score: 0.063
-
Babcock A, Moussa RK, Diaby V. Prevalence and effects of suicidal ideation diagnosis code position in claims on readmission rate estimates. Res Social Adm Pharm. 2021 06; 17(6):1174-1180.
Score: 0.062
-
Nkemdirim Okere A, Sanogo V, Balkrishnan R, Diaby V. A quantitative analysis of the effect of continuity of care on 30-day readmission and in-hospital mortality among patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):105053.
Score: 0.061
-
Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2020 Feb; 49:141-148.
Score: 0.059
-
Diaby V, Di? Kakou H, Lachaine J. Eliciting preferences for reimbursed drugs selection criteria in C?te d'Ivoire. Patient. 2011; 4(2):125-31.
Score: 0.032
-
Garg M, Venugopalan V, Vouri SM, Diaby V, Iovine NM, Park H. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study. Pharmacotherapy. 2023 09; 43(9):883-893.
Score: 0.019
-
Jiang X, Diaby V, Vouri SM, Lo-Ciganic W, Parker RL, Wang W, Chang SH, Wilson DL, Henry L, Park H. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. Am J Prev Med. 2023 01; 64(1):96-104.
Score: 0.018
-
Tran PT, Nduaguba SO, Diaby V, Choi Y, Winterstein AG. RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases. BMC Infect Dis. 2022 Aug 08; 22(1):681.
Score: 0.018
-
Jiang X, Vouri SM, Diaby V, Lo-Ciganic W, Parker R, Park H. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C. J Manag Care Spec Pharm. 2021 Oct; 27(10):1388-1402.
Score: 0.017
-
Alsuhibani A, Albogami Y, Diaby V, Friedman J, Vouri SM. Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort study. Surg Obes Relat Dis. 2021 May; 17(5):939-946.
Score: 0.016
-
Wang CY, Pham PN, Kim S, Lingineni K, Schmidt S, Diaby V, Brown J. Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States. Clin Transl Sci. 2020 03; 13(2):352-361.
Score: 0.015